AVIR

Atea Pharmaceuticals (AVIR)

About Atea Pharmaceuticals (AVIR)

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.

Details

Daily high

$5.57

Daily low

$5.42

Price at open

$5.51

52 Week High

$6.45

52 Week Low

$2.46

Market cap

432.6M

Dividend yield

0.00%

Volume

239,830

Avg. volume

255,370

P/E ratio

-2.78

Atea Pharmaceuticals News